Literature DB >> 9201908

Cis-autophosphorylation of juxtamembrane tyrosines in the insulin receptor kinase domain.

A D Cann1, R A Kohanski.   

Abstract

Receptor tyrosine kinases undergo ligand-induced dimerization that promotes kinase domain trans-autophosphorylation. However, the kinase domains of the insulin receptor are effectively dimerized because of the covalent alpha2beta2 holomeric structure. This fact has made it difficult to determine the molecular mechanism of intraholomeric autophosphorylation, but there is evidence for both cis- and trans-autophosphorylation in the absence and presence of insulin. Here, using the cytoplasmic kinase domain (CKD) of the human insulin receptor, we demonstrate that autophosphorylation in the juxtamembrane (JM) subdomain follows a cis-reaction pathway. JM autophosphorylation was independent of CKD concentration over the range 6 nM-3 microM and was characterized kinetically: Half-saturation (K(ATP)) was observed at 75 microM ATP [5 mM Mn(CH3CO2)2] with a maximal rate of 0.24 mol of PO4 (mol of CKD)(-1) min(-1). Pairwise substitutions of Phe for Tyr in the other two autophosphorylation subdomains, generated by site-directed mutagenesis, altered the kinetics of JM autophosphorylation but did not change the pathway from a cis-reaction. Tyr(1328,1334) to Phe (in the carboxy-terminal subdomain) yielded <2-fold increase in the efficiency of JM autophosphorylation, whereas Tyr(1162,1163) to Phe (in the activation loop subdomain) yielded approximately 38-fold increased efficiency of JM autophosphorylation, due predominantly to a 23-fold decreased K(ATP). These findings demonstrate basal state binding of ATP to the CKD leading to cis-autophosphorylation and novel basal state regulatory interactions among the subdomains of the insulin receptor kinase. On the basis of these results and the crystal structure of the conserved catalytic core of this kinase [Hubbard, S. R., et al. (1994) Nature 372, 746], a model is proposed which reconciles the JM cis-reaction and the activation loop cis-inhibition/trans-reaction with the complex kinetics of insulin receptor autophosphorylation [Kohanski, R. A. (1993) Biochemistry 32, 5766].

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201908     DOI: 10.1021/bi970170x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Conformational changes in the activation loop of the insulin receptor's kinase domain.

Authors:  M Frankel; S M Bishop; A J Ablooglu; Y P Han; R A Kohanski
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.

Authors:  M Frankel; A J Ablooglu; J W Leone; E Rusinova; J B Ross; R L Heinrikson; R A Kohanski
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Analysis of protein kinase autophosphorylation using expressed protein ligation and computational modeling.

Authors:  Kerry A Pickin; Sidhartha Chaudhury; Blair C R Dancy; Jeffrey J Gray; Philip A Cole
Journal:  J Am Chem Soc       Date:  2008-04-09       Impact factor: 15.419

4.  Suppression of insulin signalling by a synthetic peptide KIFMK suggests the cytoplasmic linker between DIII-S6 and DIV-S1 as a local anaesthetic binding site on the sodium channel.

Authors:  Munetaka Hirose; Yoshihiro Kuroda; Shinichi Sawa; Terumichi Nakagawa; Masashi Hirata; Masahiro Sakaguchi; Yoshifumi Tanaka
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

5.  Insulin receptor membrane retention by a traceable chimeric mutant.

Authors:  Jimena Giudice; Elizabeth A Jares-Erijman; Federico Coluccio Leskow
Journal:  Cell Commun Signal       Date:  2013-06-27       Impact factor: 5.712

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.